RSS-Feed abonnieren
DOI: 10.1055/s-0043-1777754
Ventriculovesical Shunting in a Patient with Leptomeningeal Carcinomatosis: An Alternative to VP Shunts. A Technique Report
Derivação ventriculovesical em paciente com carcinomatose leptomeníngea: Uma alternativa às DVPs. Relato de técnica
Abstract
Leptomeningeal carcinomatosis (LC) is a rare but serious complication when cancer cells infiltrate the meninges. It is most commonly associated with breast cancer, but only 5% of breast cancer patients develop it. Leptomeningeal carcinomatosis typically presents with headaches, mainly due to hydrocephalus, and the diagnosis involves a cytological analysis of cerebrospinal fluid (CSF) and/or magnetic resonance imaging (MRI) scans. The treatment of LC consists of a combination of intra-CSF chemotherapy, systemic therapy, radiation therapy, and/or supportive care, including CSF drainage. In the case herein reported, a technique known as ventriculovesical shunting was performed on a female patient with LC and breast cancer who had hydrocephalus due to this condition. This procedure is not as common as ventriculoperitoneal shunts, which can lead, in this case, to serious complications such as peritoneal carcinomatosis.
Resumo
Carcinomatose leptomeníngea (CL) é uma complicação infrequente, porém séria, que ocorre quando células cancerígenas infiltram as meninges. É mais comumente associada ao câncer de mama, mas apenas 5% dos pacientes com câncer de mama a desenvolvem. A CL apresenta-se tipicamente com dores de cabeça decorrentes principalmente da hidrocefalia, e o diagnóstico envolve uma análise citológica do líquido cefalorraquidiano (LCR) e/ou ressonância magnética (RM). O tratamento da CL envolve uma combinação de quimioterapia intra-LCR, terapia sistêmica, radioterapia e/ou cuidados de suporte, incluindo a drenagem do LCR. No caso aqui relatado, realizou-se uma técnica conhecida como derivação ventriculovesical em uma paciente feminina com CL e câncer de mama que tinha hidrocefalia em decorrência desta situação. Este procedimento não é tão comum em comparação com as derivações ventriculoperitoneais, as quais, nesse caso, podem levar à carcinomatose peritoneal.
Keywords
meningeal carcinomatosis - neoplasm metastasis - hydrocephalus - cerebrospinal fluid shunts - neurosurgeryPalavras-chave
carcinomatose meníngea - metástase neoplásica - hidrocefalia - derivações do líquido cefalorraquidiano - neurocirurgiaPublikationsverlauf
Eingereicht: 08. März 2023
Angenommen: 13. September 2023
Artikel online veröffentlicht:
02. Mai 2024
© 2024. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Franzoi MA, Hortobagyi GN. Leptomeningeal carcinomatosis in patients with breast cancer. Crit Rev Oncol Hematol 2019; 135: 85-94 DOI: 10.1016/j.critrevonc.2019.01.020.
- 2 Le Rhun E, Galanis E. Leptomeningeal metastases of solid cancer. Curr Opin Neurol 2016; 29 (06) 797-805 DOI: 10.1097/WCO.0000000000000393.
- 3 Le Rhun E, Rudà R, Devos P. et al. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe. J Neurooncol 2017; 133 (02) 419-427 DOI: 10.1007/s11060-017-2452-6.
- 4 Lee JS, Melisko ME, Magbanua MJ. et al. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. Breast Cancer Res Treat 2015; 154 (02) 339-349 DOI: 10.1007/s10549-015-3610-1.
- 5 Nevel KS, DiStefano N, Lin X. et al. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer. Neuro-oncol 2020; 22 (05) 675-683 DOI: 10.1093/neuonc/noz208.
- 6 Taillibert S, Chamberlain MC. Leptomeningeal metastasis. Handb Clin Neurol 2018; 149: 169-204 DOI: 10.1016/B978-0-12-811161-1.00013-X.
- 7 Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int 2013; 4 (Suppl 4): S265-S288 DOI: 10.4103/2152-7806.111304.
- 8 Morosanu CO, Filip GA, Nicolae L, Florian IS. From the heart to the bladder-particularities of ventricular shunt topography and the current status of cerebrospinal fluid diversion sites. Neurosurg Rev 2020; 43 (03) 847-860 DOI: 10.1007/s10143-018-1033-2.
- 9 Negrete HO, Lavelle JP, Berg J, Lewis SA, Zeidel ML. Permeability properties of the intact mammalian bladder epithelium. Am J Physiol 1996; 271 (4 Pt 2): F886-F894 DOI: 10.1152/ajprenal.1996.271.4.F886.
- 10 Ames CD, Jane Jr JA, Jane Sr JA, Campbell FG, Howards SS. A novel technique for ventriculovesical shunting of congenital hydrocephalus. J Urol 2001; 165 (04) 1169-1171 DOI: 10.1016/S0022-5347(05)66458-0.
- 11 Lukas RV, Thakkar JP, Cristofanilli M. et al. Leptomeningeal metastases: the future is now. J Neurooncol 2022; 156 (03) 443-452 DOI: 10.1007/s11060-021-03924-2.
- 12 Sandvik U, Bartek Jr J, Edström E, Jönsson M, Stenman J. Percutaneously inserted ventriculo-ureteral shunt as a salvage treatment in paediatric hydrocephalus: a technical note. Childs Nerv Syst 2023; 39 (01) 249-254 DOI: 10.1007/s00381-022-05673-7.
- 13 Matson DD. A new operation for the treatment of communicating hydrocephalus; report of a case secondary to generalized meningitis. J Neurosurg 1949; 6 (03) 238-247 DOI: 10.3171/jns.1949.6.3.0238.
- 14 West CGH. Ventriculovesical shunt. Technical note. J Neurosurg 1980; 53 (06) 858-860 DOI: 10.3171/jns.1980.53.6.0858.